Literature DB >> 18367437

Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction.

Anna Kiryk1, Tomomi Aida, Kohichi Tanaka, Pradeep Banerjee, Grzegorz M Wilczynski, Ksenia Meyza, Ewelina Knapska, Robert K Filipkowski, Leszek Kaczmarek, Wojciech Danysz.   

Abstract

GLT1 is one of the major transporters responsible for maintenance of glutamate homeostasis in the brain. In the present study, glutamate transporter 1-deficient GLT1 homozygous (-/-) and heterozygous (+/-) mice were investigated with the intention that they may provide a model of hyperglutamatergic state resulting in various behavioral alterations. The GLT1 (-/-) mice had lower body and brain weight, mild neuronal loss in CA1 hippocampal region as well as focal gliosis and severe focal neuronal paucity in layer II of the neocortex. The short life-span of GLT1 (-/-) precluded us from systematic behavioral studies in these mice. In contrast, GLT1 (+/-) mice exhibiting a 59% decrease in GLT1 immunoreactivity in their brain tissue, showed no apparent morphological brain abnormalities, and their life-span was not markedly different from controls. Behaviorally, GLT1 (+/-) presented moderate behavioral alterations compared to their wildtype littermates, such as: mild sensorimotor impairment, hyperlocomotion (at 3 month of age only), lower anxiety (at 6 months), better learning of cue-based fear conditioning but worse context-based fear conditioning. Our results suggest that GLT1 (+/-) mice may serve as a potentially useful model to study neurodegenerative disease conditions with mild hyperglutamatergic activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367437     DOI: 10.1007/bf03033364

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  42 in total

1.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

2.  Excitatory amino acids and Parkinson's disease.

Authors:  W J Schmidt; M Bubser; W Hauber
Journal:  Trends Neurosci       Date:  1990-02       Impact factor: 13.837

3.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

4.  Expression cloning of a rat glutamate transporter.

Authors:  K Tanaka
Journal:  Neurosci Res       Date:  1993-02       Impact factor: 3.304

5.  Differential vulnerability of central neurons of the rat to quinolinic acid.

Authors:  R Schwarcz; C Köhler
Journal:  Neurosci Lett       Date:  1983-07-15       Impact factor: 3.046

Review 6.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

7.  D3 dopamine receptor-deficient mouse: evidence for reduced anxiety.

Authors:  H Steiner; S Fuchs; D Accili
Journal:  Physiol Behav       Date:  1997-12-31

8.  Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures.

Authors:  M E Harris; Y Wang; N W Pedigo; K Hensley; D A Butterfield; J M Carney
Journal:  J Neurochem       Date:  1996-07       Impact factor: 5.372

9.  Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

Authors:  E Masliah; M Alford; R DeTeresa; M Mallory; L Hansen
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

Review 10.  Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: "use it and lose it".

Authors:  J T Greenamyre
Journal:  Neurobiol Aging       Date:  1991 Jul-Aug       Impact factor: 4.673

View more
  29 in total

1.  Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment.

Authors:  Lu-Lin Jiang; Bing Zhu; Yingjun Zhao; Xiaoguang Li; Tongfei Liu; Juan Pina-Crespo; Lisa Zhou; Wenxi Xu; Maria J Rodriguez; Haiyang Yu; Don W Cleveland; John Ravits; Sandrine Da Cruz; Tao Long; Dongxian Zhang; Timothy Y Huang; Huaxi Xu
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

2.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Chronic Hyponatremia Causes Neurologic and Psychologic Impairments.

Authors:  Haruki Fujisawa; Yoshihisa Sugimura; Hiroshi Takagi; Hiroyuki Mizoguchi; Hideyuki Takeuchi; Hisakazu Izumida; Kohtaro Nakashima; Hiroshi Ochiai; Seiji Takeuchi; Atsushi Kiyota; Kazuya Fukumoto; Shintaro Iwama; Yoshiko Takagishi; Yoshitaka Hayashi; Hiroshi Arima; Yukio Komatsu; Yoshiharu Murata; Yutaka Oiso
Journal:  J Am Soc Nephrol       Date:  2015-09-16       Impact factor: 10.121

4.  Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures.

Authors:  Abhijeet Sharma; Syed Faraz Kazim; Chloe S Larson; Aarthi Ramakrishnan; Jason D Gray; Bruce S McEwen; Paul A Rosenberg; Li Shen; Ana C Pereira
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

5.  Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions.

Authors:  Sunil Goodwani; P S S Rao; Richard L Bell; Youssef Sari
Journal:  Brain Res       Date:  2015-07-10       Impact factor: 3.252

6.  Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice.

Authors:  Yun Zhou; Leonie F Waanders; Silvia Holmseth; Caiying Guo; Urs V Berger; Yuchuan Li; Anne-Catherine Lehre; Knut P Lehre; Niels C Danbolt
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

7.  Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.

Authors:  Geraldine T Petr; Laurel A Schultheis; Kayla C Hussey; Yan Sun; Janet M Dubinsky; Chiye Aoki; Paul A Rosenberg
Journal:  Eur J Neurosci       Date:  2013-04-16       Impact factor: 3.386

8.  Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-β1 in the CNS.

Authors:  Thomas Koeglsperger; Shaomin Li; Christian Brenneis; Jessica L Saulnier; Lior Mayo; Yijun Carrier; Dennis J Selkoe; Howard L Weiner
Journal:  Glia       Date:  2013-03-28       Impact factor: 7.452

Review 9.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

10.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.